President Muhammadu Buhari’s two-week medical vacation in London, the United Kingdom (UK), does not require the transfer of power to Vice-President Yemi Osinbajo, it was learnt yesterday. The President left
President Muhammadu Buhari’s two-week medical vacation in London, the United Kingdom (UK), does not require the transfer of power to Vice-President Yemi Osinbajo, it was learnt yesterday. The President left
Deputy Chief of Staff to Abia Governor, Chief Agwu Ukpai, is dead Ukpai’s death was said to have shaken members of the Peoples Democratic Party (PDP) and those within government
From EVEREST EZIHE, Owerri Worried by campaign of calumny, propaganda and blackmail being dishes out from certain quarters, against the on going Covid-19 vaccination, Princess Calista Anene-Ahmed has advised Imolites
The Federal Government has dispelled the possibility of any fake COVID-19 vaccines being administered or sold by unauthorised institution in the country. This is contained in a circular by Dr
Doctors under the aegis of the Nigerian Association of Resident Doctors (NARD) are set to begin an indefinite strike from April 1. The industrial action is sequel to expiration of
Delta Police Commissioner Ari Mohammed Ali at the weekend appealed to medical practitioners to treat patients with gunshot wounds without waiting for police reports. He said the police could be
Super Eagles’ Alex Iwobi has tested positive for COVID-19 following mandatory tests taken alongside other players and staff members. It was gathered that Iwobi will consequently be missing the 2021
The Federal Government on Saturday raised alarm over fake covid-19 vaccines currently in circulation in Africa. It stated that about 3,000 of the fake vaccines, which were Africa-bound from China
A total of 325,514 Nigerians have received the first dose of the COVID-19 vaccine as at March 25, 2021, the National Primary Health Care Development Agency (NPHCDA) has stated. Lagos,
AstraZeneca said its COVID-19 vaccine was 76 percent effective at preventing symptomatic illness in a new analysis of its key trial in the United States slightly lower than the level